NMRA

Neumora Therapeutics INC

+$28.3M

Net Activity

Institutions Holding

114

Popularity Rank

#4184

Avg Weight

0.08%

Total Value

$141.2M

Ownership Trend

114 institutions currently hold NMRA, with 53 net buyers and 45 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

45

Net Buying Institutions

53

Key Holders

View all 114 holding institutions

Quarterly Activity

Recent Activity

+$69.2M

Total Buy Value

$41.0M

Total Sell Value

New buy20
Trim34
Add33
Sold out11

53

Net Buyers

45

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NEUMORA THERAPEUTICS INC (NMRA)?
Major stakeholders currently include Siren, L.L.C. ($16.6M), Softbank Group CORP. ($11.9M), Perceptive Advisors LLC ($10.0M). Based on the latest 13F filings, there are a total of 114 tracked investment funds and institutions maintaining positions in NMRA.
What is the overall institutional sentiment toward NMRA recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $28.3M, driven by 53 managers accumulating shares while 45 reduced their exposure.
Which institutions have been selling or reducing their NMRA positions?
In the latest period, 34 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $41.0M.
Are there any notable investors adding NMRA to their portfolios?
Yes, buying activity remains notable. 20 institutions opened new positions in {ticker}, and 33 existing holders added to their shares. The total reported buy value for the quarter amounted to $69.2M.

Related Stocks